newsfilter
← Latest News
GlobeNewswire·

Oyster Point Pharma To Report First Quarter 2022 Financial Results On May 5, 2022

PRINCETON, N.J., May 03, 2022 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (NASDAQ:OYST) a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ophth